In accordance with the terms of the 7.875% Series A Cumulative Redeemable Preferred Stock of Annaly Capital Management, Inc. (NYSE:NLY), the Board of Directors of Annaly has declared a Series A Preferred Stock cash dividend for the first quarter 2015 of $0.492188 per share of Series A Preferred Stock. This dividend is payable on March 31, 2015, to Series A Preferred Stock shareholders. On Friday shares of Annaly Capital Management, Inc. (NYSE:NLY) closed at $10.43. Company’s sales growth for last 5 years was 14.00% and EPS growth for next 5 years is recorded as -3.07%.
Microsoft Corporation (NASDAQ:MSFT) sued Kyocera Corp for patent infringement on Friday, alleging the Japanese company’s Duraforce, Hydro and Brigadier cell phone lines violate seven Microsoft patents. Microsoft asked a Seattle federal judge to impose a U.S. sales injunction against Kyocera’s infringing products, according to the lawsuit. Microsoft Corporation (NASDAQ:MSFT) in last trading activity fell -1.74% to close at $42.36. Company weekly performance is -3.40% while its quarterly performance stands at -11.27%. Microsoft Corporation (NASDAQ:MSFT) is -14.22% away from its 52 week high.
Crown Crafts, Inc. (NASDAQ:CRWS) announced that E. Randall Chestnut, Chairman, President and Chief Executive Officer, will present at the 27th Annual ROTH Growth Stock Conference to be held at The Ritz Carlton, Laguna Niguel in Dana Point, CA on March 8-11, 2015. The Company’s presentation is scheduled for Monday, March 9, 2015 at 9:00 a.m. Pacific Daylight Time. On last trading day Crown Crafts, Inc. (NASDAQ:CRWS) fell -0.24% to close at $8.34. Its volatility for the week is 1.82% while volatility for the month is 2.17%. CRWS’s sales growth for past 5 years was -1.40% and its EPS growth for past 5 years was 18.40%. Crown Crafts, Inc. (NASDAQ:CRWS) monthly performance is 3.77%.
Leerink Swann cut their target price on shares of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) from $18.00 to $15.00 in a research note issued on Friday. The firm currently has an “outperform” rating on the stock. Leerink Swann’s target price indicates a potential upside of 61.81% from the company’s current price. Raptor Pharmaceuticals Corp. (NASDAQ:RPTP) has 1.30% insider ownership while its institutional ownership stands at 55.10%. In last trading activity company’s stock closed at $10.86.
On March 6, it was reported that, Merck & Co. Inc. (NYSE:MRK) entered into a collaboration with Eisai Co., Ltd. for the evaluation of the safety, tolerability and efficacy of Merck’s Keytruda (anti-PD-1 therapy) in combination with Eisai’s oncology compounds, including Lenvima (a multi-targeting RTK inhibitor) and Halaven (a microtubule dynamics inhibitor) across multiple studies. On Friday shares of Merck & Co. Inc. (NYSE:MRK) closed at $56.84. Company’s sales growth for last 5 years was 9.00% and EPS growth for next 5 years is recorded as 4.74%.